Search
Search Results
##search.searchResults.foundPlural##
-
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3066PDF: 869HTML: 1525Fig.1 CHL-R paper: 196Fig 2 CHL-R paper: 225 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4016PDF: 1544HTML: 853 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3153PDF: 978HTML: 1991 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2564PDF: 1055HTML: 99 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
963PDF: 822Suppl. Files: 440HTML: 273 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3643PDF: 1212HTML: 3867Untitled: 194Untitled: 243 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4367PDF: 1878HTML: 17712 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1567PDF: 770HTML: 1219Figure 1: 155Figure 2: 172Figure 3: 167 -
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
710PDF: 455HTML: 6249 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1372PDF: 1177HTML: 486 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3802PDF: 1436HTML: 8491 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1704PDF: 855HTML: 362Fig1: 218Fig.2: 237Fig. 3: 166Fig. 5: 179Fig. 4: 202 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1517PDF: 950HTML: 163 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
917PDF: 573Html: 149 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2533PDF: 1573HTML: 2339Table1: 180 -
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3444PDF: 955HTML: 389Table 1.: 215 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12270PDF: 1649HTML: 4146Cover letter: 185Figure 1: 188 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1522PDF: 828HTML: 1022Picture 1: 155 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1306PDF: 812HTML: 10021cover letter to the editor: 152tile page: 238 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1348PDF: 801HTML: 3104 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3827PDF: 1070HTML: 414







